갑상선 수술의 합병증을 최소화하려면? = How to minimize the complications of thyroid surgery
|
이강대, 김영준
|
p. 251-258
|
|
|
|
대한갑상선학회 갑상선분화암 진료권고안 2024 어떻게 바뀌었나 = Updates in the 2024 Korean Thyroid Association Clinical Practice Guidelines for Differentiated Thyroid Cancer : from diagnosis to initial treatment : 진단부터 초기치료까지
|
이은경
|
p. 259-265
|
|
|
|
Extrathyroidal extension in papillary thyroid cancer could be predicted through preoperative sonography
|
Go Eun Yang, Sung Whi Cho, Yoon Jong Ryu, Kyoung Yul Lee, Hwan Soo Kim, Taek Geun Ohk, Hoonsung Choi
|
p. 266-271
|
|
|
|
Monocarboxylate transporter 4 expression in thyroid cancer
|
Chae A Kim, Jungmin Yoo, Woo Kyung Lee, Dong Eun Song, Won Gu Kim, Min Ji Jeon
|
p. 272-276
|
|
|
|
Changing trends of thyroid cancer clinical characteristics and treatment pattern in South Korea : insights from an institutional database and the Korean Cancer Center registry database
|
Yung Jee Kang, Nayeon Choi, Jungirl Seok, Sun Wook Kim, Tae-Hyuk Kim, Jae Hoon Chung, Young-Ik Son, Man Ki Chung
|
p. 277-285
|
|
|
|
Are TERT promoter mutations a poor prognostic factor in anaplastic thyroid carcinoma?
|
Hyun Jin Ryu, Young Lyun Oh, Jung Heo, Hyunju Park, Tae Hyuk Kim, Sun Wook Kim, Jae Hoon Chung
|
p. 286-294
|
|
|
|
Methimazole-induced insulin autoimmune syndrome in a Korean patient with Graves’ disease treated with propylthiouracil : a case report and literature review
|
Sun Hee Kim, Cho-ok Baek, Sun Kyung Song, Ji Hye Kim
|
p. 295-298
|
|
|
|
BRAF/MEK inhibitors in downstaging BRAF[V600E] mutated papillary thyroid cancer to allow resection : case report and literature review
|
Lorin Dodbiba, Han Zhang, Meera Luthra, Brandon Meyers
|
p. 299-303
|
|
|
|
Diagnosing dysphagia due to thyroid nodules by thyroid ultrasound, a case series
|
Zarwa Idrees, Michael Morkos
|
p. 304-308
|
|
|
|
정상 칼시토닌 수치를 보인 갑상선수질암 1례 = Medullary thyroid carcinoma with normal calcitonin level
|
장명철, 이원애
|
p. 309-313
|
|
|
|